These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11545770)

  • 1. Association of eptifibatide and acute profound thrombocytopenia.
    Hongo RH; Brent BN
    Am J Cardiol; 2001 Aug; 88(4):428-31. PubMed ID: 11545770
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute profound thrombocytopenia associated with readministration of eptifibatide: case report and review of the literature.
    Russell KN; Schnabel JG; Rochetto RP; Tanner MC
    Pharmacotherapy; 2009 Jul; 29(7):867-74. PubMed ID: 19558261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe thrombocytopenia possibly related to readministration of eptifibatide.
    Paradiso-Hardy FL; Madan M; Radhakrishnan S; Hurden S; Cohen EA
    Catheter Cardiovasc Interv; 2001 Sep; 54(1):63-7. PubMed ID: 11553950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute profound thrombocytopenia with second exposure to eptifibatide associated with a strong antibody reaction.
    Attaya S; Kanthi Y; Aster R; McCrae K
    Platelets; 2009 Feb; 20(1):64-7. PubMed ID: 19172524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible thrombocytopenia associated with eptifibatide.
    Yoder M; Edwards RF
    Ann Pharmacother; 2002 Apr; 36(4):628-30. PubMed ID: 11918511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute profound thrombocytopenia associated with eptifibatide therapy.
    Nagge J; Jackevicius C; Dzavik V; Ross JR; Seidelin P
    Pharmacotherapy; 2003 Mar; 23(3):374-9. PubMed ID: 12627937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eptifibatide-induced thrombocytopenia.
    Refaat M; Smith AJ; Edmundowicz D
    J Thromb Thrombolysis; 2008 Apr; 25(2):204-6. PubMed ID: 18008040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytopenia associated with antithrombotic therapy in acute coronary syndrome.
    Ho R; Kayser SR
    Prog Cardiovasc Nurs; 2003; 18(4):198-200. PubMed ID: 14605523
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent acute profound thrombocytopenia related to readministration of eptifibatide.
    Cheema AA; Teklinski AH; Maria V; Chilukuri K; Frank JJ; Gosselin MO
    J Interv Cardiol; 2006 Feb; 19(1):99-103. PubMed ID: 16483348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and time course of thrombocytopenia with abciximab and eptifibatide in patients undergoing percutaneous coronary intervention.
    Fahdi IE; Saucedo JF; Hennebry T; Ghani M; Sadanandan S; Garza-Arreola L
    Am J Cardiol; 2004 Feb; 93(4):453-5. PubMed ID: 14969621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty.
    Tempelhof MW; Benzuly KH; Fintel D; Krichavsky MZ
    Tex Heart Inst J; 2012; 39(1):86-91. PubMed ID: 22412237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eptifibatide-induced thrombocytopenia and coronary bypass operation.
    Tanaka KA; Vega JD; Kelly AB; Hanson SR; Levy JH
    J Thromb Haemost; 2003 Feb; 1(2):392-4. PubMed ID: 12871522
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute profound thrombocytopenia after use of eptifibatide for coronary stenting.
    Salengro E; Mulvihill NT; Farah B
    Catheter Cardiovasc Interv; 2003 Jan; 58(1):73-5. PubMed ID: 12508201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megakaryocyte impairment by eptifibatide-induced antibodies causes prolonged thrombocytopenia.
    Greinacher A; Fuerll B; Zinke H; Müllejans B; Krüger W; Michetti N; Motz W; Schwertz H
    Blood; 2009 Aug; 114(6):1250-3. PubMed ID: 19429867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eptifibatide-induced acute profound thrombocytopenia presenting as refractory hypotension.
    Rezkalla SH; Hayes JJ; Curtis BR; Aster RH
    Catheter Cardiovasc Interv; 2003 Jan; 58(1):76-9. PubMed ID: 12508202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eptifibatide-induced thrombocytopenia and thrombosis.
    Epelman S; Nair D; Downey R; Militello M; Askari AT
    J Thromb Thrombolysis; 2006 Oct; 22(2):151-4. PubMed ID: 17008982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eptifibatide-Induced Profound Thrombocytopenia After Percutaneous Intervention for Acute Coronary Syndrome: A Challenging Clinical Scenario.
    Bhatia N; Sawyer RD; Ikram S
    Methodist Debakey Cardiovasc J; 2017; 13(4):248-252. PubMed ID: 29744018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute thrombocytopenia associated with eptifibatide therapy.
    Khaykin Y; Paradiso-Hardy FL; Madan M
    Can J Cardiol; 2003 Jun; 19(7):797-801. PubMed ID: 12813613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eptifibatide-associated acute, profound thrombocytopenia.
    Coons JC; Barcelona RA; Freedy T; Hagerty MF
    Ann Pharmacother; 2005 Feb; 39(2):368-72. PubMed ID: 15644467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eptifibatide-induced thrombocytopenia and circulating procoagulant platelet-derived microparticles in a patient with acute coronary syndrome.
    Morel O; Jesel L; Chauvin M; Freyssinet JM; Toti F
    J Thromb Haemost; 2003 Dec; 1(12):2685-7. PubMed ID: 14675110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.